IMUREL 25 mg

DRUG4 trials

Sponsors

Assistance Publique Hopitaux De Paris, Centre Hospitalier Universitaire Amiens Picardie, Les Hopitaux Universitaires De Strasbourg

Conditions

Antisynthetase syndrome-related interstitial lung diseaseCrohn’s DiseaseEosinophilic granulomatosis with polyangiitis (EGPA)formerly called Churg-Strauss syndromekidney transplant

Phase 2

Immunosuppression regimen reduction in kidney transplantation recipients admitted to the intensive care unit in the setting of septic shock and/or acute respiratory failure: an open multicentric randomized phase IV study

Not yet recruitingCTIS2024-518493-14-00

Les Hopitaux Universitaires De Strasbourgkidney transplant

Target: 212Updated: 2025-11-19

Phase 3

Comparison of azathioprine to methotrexate in combination therapy with adalimumab in Crohn’s Disease: an open-label randomized controlled trial

Not yet recruitingCTIS2024-514633-38-00

Centre Hospitalier Universitaire Amiens PicardieCrohn’s Disease

Target: 166Updated: 2025-10-15

Cyclophosphamide and Azathioprine vs Tacrolimus in antisynthetase syndrome-related interstitial lung disease : multicentric randomized phase III trial (CATR-PAT)

RecruitingCTIS2024-511868-83-00

Assistance Publique Hopitaux De ParisAntisynthetase syndrome-related interstitial lung disease

Start: 2021-02-05Target: 76Updated: 2026-01-16

E-merge - Evaluation of MEpolizumab-based regimen Compared to Conventional Therapeutic Strategy For Remission Induction In Patients With Eosinophilic Granulomatosis With Polyangiitis. Prospective, randomized, controlled, double-blind study

CompletedCTIS2024-513653-75-00

Assistance Publique Hopitaux De ParisEosinophilic granulomatosis with polyangiitis (EGPA), formerly called Churg-Strauss syndrome

Start: 2022-05-30End: 2025-09-05Target: 100Updated: 2025-08-12